3
Participants
Start Date
August 1, 2019
Primary Completion Date
February 24, 2020
Study Completion Date
February 24, 2020
RVT-1201
RVT-1201 600 mg immediate-release tablet
Placebo
Inactive pill manufactured to mimic RVT-1201 600 mg immediate-release tablet
George Washington Medical Faculty Associates - Pulmonary Hypertension Program, Washington D.C.
Duke University Medical Center, Durham
University of Florida, Gainesville
Central Florida Pulmonary Group, P.A., Orlando
San Marcus Research Clinic, Inc., Miami Lakes
Kentuckiana Pulmonary Research Center, Louisville
Cleveland Clinic, Cleveland
Pulmonary Research Institute of Southeast Michigan, Farmington Hills
University of Chicago Medical Center, Chicago
Washington University School of Medicine, St Louis
Louisiana State University Health Sciences Center, New Orleans
University of Texas Southwestern Medical Center, Dallas
University of Texas Health Science Center at Houston, McGovern Medical School, Houston
University of Colorado, Aurora
Pulmonary Associates, PA, Phoenix
SBPA Research LLC, Santa Barbara
University of California Davis Medical Center, Sacramento
Oregon Health & Science University, Portland
Boston Children's Hospital, Boston
Baystate Medical Center, Springfield
University of Calgary, Calgary
University of Alberta, Edmonton
London Health Sciences Centre, London
Lead Sponsor
Collaborators (2)
Altavant Sciences, Inc.
UNKNOWN
PPD Development, LP
INDUSTRY
Altavant Sciences GmbH
INDUSTRY